Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our blog, On Cancer.

and/or

344 News Items found

In the Lab

Researchers Discover New Strategy for Foiling Drug Resistance in Aggressive Lymphoma

A two-drug combination may hold the key to overcoming resistance in an aggressive form of non-Hodgkin lymphoma.

Microscopic image of lymphoma cells stained purple.

In the Lab

This Newly Discovered Organelle Is Fierce

It’s not every day that scientists discover a new part of the cell. Two biologists from the Sloan Kettering Institute just did.

3D organelle

Finding

Adding Low-Dose Radiation Could Make CAR T Therapy More Effective, Study Finds

The treatment combination appears to boost chimeric antigen receptor (CAR) T cells’ ability to kill cancer cells in solid tumors.

Blue cancer cell with a target on it

In the Clinic

New Study Shows Immunotherapy and Chemo Combination Extends Survival for People with Hard-to-Treat Breast Cancer

MSK experts comment on a new international study that looked at combination therapy for triple-negative breast cancer.

Elizabeth Comen with a patient

In the Lab

Researchers Zero In on the Cause of Lymphedema, a Debilitating Cancer Complication

Learn how an MSK laboratory is bringing much-needed focus to cancer-related lymphedema and investigating new ways to prevent the complication.

Confocal microscopic image of mouse lymphedema tissue with staining for immune cells and lymphatic vessels.

In the News

Former MSK Immunologist James Allison Wins Nobel Prize in Medicine

Dr. Allison is being honored for discovering how to take the brakes off cancer-fighting immune cells.

James Allison

FDA Grants Breakthrough Therapy Designation to Naxitamab for Neuroblastoma

Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA.

  • Friday, September 28, 2018

Feature

In Conversation: Two Neuroblastoma Experts on Their Hopes for the Future

Hear from two MSK scientists who are leading the charge to develop new drugs for an aggressive pediatric cancer.

MSK medical oncologist Nai-Kong Cheung

In The Clinic

Proof that Fecal Transplants Can Restore a Gut’s Natural Balance of Microbes

A clinical trial at MSK has shown that fecal transplants are safe in people who have had stem cell or bone marrow transplants.

Ying Taur

In the Clinic

How Acute Myeloid Leukemia Is Treated at MSK: An Interview with Martin Tallman

Learn about the latest advances in treatment for AML and how people can benefit from receiving their treatment at MSK.

Leukemia Service Chief Martin Tallman